《大行報告》匯豐研究下調中國平安(02318.HK)目標價至62元 評級「買入」
匯豐研究發表研究報告指,由於投資者對新業務價值前景、資產進一步減值風險以及主要管理層變動感到擔憂,令中國平安(02318.HK)股價繼續受挫。
該行指出,平安首三季新業務價值表現向好,按年增長41%,第三季亦增長29%,管理層更展望新業務價值明年可實現增長,但未知行業自今年7月底起停止銷售3.5%預定利率產品,會對新業務價值及首年保險有多少影響。
匯豐研究預期,明年保險業務發展策略將進一步演變,壽險業務「3+2」策略重點在於三個指標及兩方面的控制;預期財險會將重點放在新能源汽車保險,並平衡個人與團體非汽車保險的發展。
匯豐研究維持對平安的「買入」評級,將2023至2025年IFRS每股盈利預測下調24.8%、6.3%及8.5%,目標價從65元下調至62元,現價相當於今年預測市賬率約0.7倍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.